AI assistant
Sending…
Capstone Holding Corp. — Director's Dealing 2016
Nov 14, 2016
35323_dirs_2016-11-14_c3d56236-3d23-4d6b-89d5-98ddf2267853.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2016-11-10
Reporting Person: HOWSE ELWOOD D (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-10 | Stock Option (Right to Buy) | $0.05 | A | 40000 | Acquired | 2026-11-10 | Common Stock (40000) | Direct |
More from Capstone Holding Corp.
Interim / Quarterly Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 8
Annual Report
2026
May 7
Proxy Solicitation & Information Statement
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Apr 23
Annual Report
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Apr 16